These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29059230)

  • 21.
    An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
    Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
    Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y; Bostick DL; Sullivan CB; Myers JL; Griesemer SB; Stgeorge K; Plotkin JB; Hensley SE
    J Virol; 2013 Sep; 87(17):9904-10. PubMed ID: 23824816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
    Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
    Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z; Zhou H; Jin H
    Vaccine; 2010 May; 28(24):4079-85. PubMed ID: 20399830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.
    Liu F; Gross FL; Jefferson SN; Holiday C; Bai Y; Wang L; Zhou B; Levine MZ
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses.
    Allen JD; Ross TM
    Sci Rep; 2021 Mar; 11(1):4554. PubMed ID: 33654128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    Abbadi N; Nagashima K; Pena-Briseno A; Ross TM; Mousa JJ
    J Virol; 2022 Aug; 96(16):e0089622. PubMed ID: 35916534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
    Koel BF; Burke DF; Bestebroer TM; van der Vliet S; Zondag GC; Vervaet G; Skepner E; Lewis NS; Spronken MI; Russell CA; Eropkin MY; Hurt AC; Barr IG; de Jong JC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA; Smith DJ
    Science; 2013 Nov; 342(6161):976-9. PubMed ID: 24264991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.
    Raymond DD; Stewart SM; Lee J; Ferdman J; Bajic G; Do KT; Ernandes MJ; Suphaphiphat P; Settembre EC; Dormitzer PR; Del Giudice G; Finco O; Kang TH; Ippolito GC; Georgiou G; Kepler TB; Haynes BF; Moody MA; Liao HX; Schmidt AG; Harrison SC
    Nat Med; 2016 Dec; 22(12):1465-1469. PubMed ID: 27820604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus.
    Lin Q; Li T; Chen Y; Lau SY; Wei M; Zhang Y; Zhang Z; Yao Q; Li J; Li Z; Wang D; Zheng Q; Yu H; Gu Y; Zhang J; Chen H; Li S; Xia N
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    Gouma S; Furey C; Santos JJS; Parkhouse K; Weirick M; Muramatsu H; Pardi N; Fan SHY; Weissman D; Hensley SE
    J Virol; 2023 Jan; 97(1):e0172322. PubMed ID: 36533954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine.
    Chen H; Alvarez JJS; Ng SH; Nielsen R; Zhai W
    Clin Infect Dis; 2019 Sep; 69(7):1198-1204. PubMed ID: 30561532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting influenza antigenicity from Hemagglutintin sequence data based on a joint random forest method.
    Yao Y; Li X; Liao B; Huang L; He P; Wang F; Yang J; Sun H; Zhao Y; Yang J
    Sci Rep; 2017 May; 7(1):1545. PubMed ID: 28484283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.
    Ndifon W; Wingreen NS; Levin SA
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8701-6. PubMed ID: 19439657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticipating time-dependent antigenic variants of influenza A (H3N2) viruses.
    Adabor ES
    Infect Genet Evol; 2019 Jan; 67():67-72. PubMed ID: 30391719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    Suntronwong N; Klinfueng S; Vichiwattana P; Korkong S; Thongmee T; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(12):e0189511. PubMed ID: 29252990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Oseltamivir on the Hemagglutination Test and Hemagglutination Inhibition Test of the Influenza A(H3N2) Virus in China.
    Cheng Y; Huang W; Li X; Wei H; Tan M; Zhao X; Yang L; Xiao N; Wang D; Shu Y
    Bing Du Xue Bao; 2017 Jan; 33(1):13-18. PubMed ID: 30702816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.